MeSH tree: C23.888.144
In November 2025, the White House announced pricing deals with multiple pharmaceutical manufacturers to lower domestic prices for glucagon-like peptide-1 receptor agonist drugs (GLP-1RAs) including Ozempic, Wegovy, Mounjaro, ...
7 hours ago
0
0
Obesity has long been the invisible health crisis looming over humanity, with rates climbing globally. There is some positive news now emerging from a multi-decade study spanning several nations. A recent study published ...
New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) shows that following treatment with GLP-1 drugs for obesity, most weight loss is fat mass (80–85%) and relative muscle mass ...
May 16, 2026
0
9
A meta-analysis of 32 studies and 43,618 adults presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) shows that use of new classes of obesity drugs for weight loss is associated with a clinically ...
May 15, 2026
0
6
New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey, shows that rapid weight loss (RWL) is much more effective than gradual weight loss (GWL) in both achieving higher weight loss and ...
May 15, 2026
0
8
Weight loss followed by weight regain, commonly known as "yo-yo dieting" or weight cycling, is often portrayed as harmful, even more damaging than remaining overweight. But a new comprehensive analysis published in The Lancet ...
May 15, 2026
0
14
New research presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) shows the use of the new GLP-1 class of obesity drugs in people with asthma is associated with a 26% fall in the number of asthma ...
May 15, 2026
0
5
A comparative study, presented at ESGE Days 2026, has found that endoscopic sleeve gastroplasty (ESG) is associated with significantly greater short-term weight loss than oral semaglutide in adults with obesity.
May 14, 2026
0
3
Understanding how obesity has been portrayed in art across the ages can make doctors more empathetic and less judgmental, which should lead to their patients achieving better outcomes, new research at the European Congress ...
May 14, 2026
0
5
A weekly dose of semaglutide (2.4 mg) leads to a clinically significant reduction in body mass index (BMI) and related health outcomes in young adults with severe obesity who are treatment resistant following hospital-based ...
May 14, 2026
0
2
